Marshall Wace, LLP Natera, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Natera, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 451,046 shares of NTRA stock, worth $68.2 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

451,046

Previous 958,383 52.94%

Holding current value

$68.2 Million

Previous $104 Million 44.76%

% of portfolio

0.07%

Previous 0.14%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$97.75 - $129.67 $49.6 Million - $65.8 Million	-507,337 Reduced 52.94%	451,046 $57.3 Million
Q2 2024 Aug 14, 2024	BUY	$85.28 - $112.6 $28.5 Million - $37.7 Million	334,630 Added 53.65%	958,383 $104 Million
Q1 2024 May 15, 2024	BUY	$59.21 - $92.9 $11.1 Million - $17.4 Million	186,852 Added 42.77%	623,753 $57 Million
Q4 2023 Feb 14, 2024	SELL	$37.55 - $62.64 $14.2 Million - $23.6 Million	-377,249 Reduced 46.34%	436,901 $27.4 Million
Q3 2023 Nov 14, 2023	SELL	$43.4 - $62.52 $25.9 Million - $37.3 Million	-596,957 Reduced 42.3%	814,150 $36 Million
Q2 2023 Aug 14, 2023	BUY	$47.08 - $55.16 $3.92 Million - $4.6 Million	83,352 Added 6.28%	1,411,107 $68.7 Million
Q1 2023 May 15, 2023	SELL	$36.57 - $58.29 $6.01 Million - $9.58 Million	-164,370 Reduced 11.02%	1,327,755 $73.7 Million
Q4 2022 Feb 14, 2023	BUY	$34.17 - $47.91 $8.98 Million - $12.6 Million	262,940 Added 21.39%	1,492,125 $59.9 Million
Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $1.06 Million - $1.62 Million	-28,641 Reduced 2.28%	1,229,185 $53.9 Million
Q2 2022 Aug 15, 2022	SELL	$28.13 - $44.54 $4.32 Million - $6.84 Million	-153,680 Reduced 10.89%	1,257,826 $44.6 Million
Q1 2022 May 16, 2022	SELL	$30.32 - $91.33 $12.3 Million - $36.9 Million	-404,413 Reduced 22.27%	1,411,506 $57.4 Million
Q4 2021 Feb 14, 2022	BUY	$86.26 - $119.0 $39.3 Million - $54.3 Million	456,158 Added 33.55%	1,815,919 $170 Million
Q3 2021 Nov 15, 2021	BUY	$100.17 - $126.36 $9.18 Million - $11.6 Million	91,617 Added 7.22%	1,359,761 $152 Million
Q2 2021 Aug 13, 2021	BUY	$86.05 - $119.72 $8.1 Million - $11.3 Million	94,131 Added 8.02%	1,268,144 $144 Million
Q1 2021 May 17, 2021	BUY	$91.47 - $124.36 $24 Million - $32.7 Million	262,759 Added 28.83%	1,174,013 $119 Million
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $60.7 Million - $102 Million	911,254 New	911,254 $90.7 Million
Q2 2020 Aug 13, 2020	SELL	$26.36 - $49.86 $1.17 Million - $2.21 Million	-44,283 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$17.27 - $40.17 $764,767 - $1.78 Million	44,283 New	44,283 $1.32 Million
Q2 2019 Aug 14, 2019	SELL	$17.75 - $27.58 $227,022 - $352,748	-12,790 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$11.34 - $20.62 $145,038 - $263,729	12,790 New	12,790 $264,000

Others Institutions Holding NTRA

# of Institutions

522

Shares Held

119M

Call Options Held

298K

Put Options Held

185K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $14.7B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Natera, Inc. Transaction History